The Ron receptor tyrosine kinase regulates acute lung injury and suppresses nuclear factor κB activation

Shock

Volumn 27, Issue 3, 2007, Pages 274-280

  Lentsch, Alex B ^a   Pathrose, Peterson ^a   Kader, Sarah ^a   Kuboki, Satoshi ^a   Collins, Margaret H ^a   Waltz, Susan E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Hepatocyte growth factor like protein; Inflammation; Receptor tyrosine kinase; Transcription factors

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR; ALBUMIN; BACTERIUM LIPOPOLYSACCHARIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOPEROXIDASE; PROTEIN TYROSINE KINASE; RON RECEPTOR TYROSINE KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; LUNG ALVEOLUS WALL; LUNG INJURY; MALE; MOUSE; MUTANT; NEUTROPHIL; NONHUMAN; PNEUMONIA; REGULATORY MECHANISM; WILD TYPE;

ACUTE DISEASE; ANIMALS; BRONCHOALVEOLAR LAVAGE; CYTOKINES; I-KAPPA B KINASE; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, TRANSGENIC; NF-KAPPA B; NITRITES; PEROXIDASE; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 33847051151     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000239755.82711.89     Document Type: Article

References (44)

1. Bass TL, Miller PK, Campbell DB, Russell GB: Traumatic adult respiratory distress syndrome. Chest Surg Clin N Am 7:429-442, 1997.
2. Fantini GA, Conte MS: Pulmonary failure following lower torso ischemia: clinical evidence for a remote effect of reperfusion injury. Am Surg 61:316-319, 1995.
3. Hudson LD, Milberg JA, Anardi D, Maunder RJ: Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151(2 pt 1):293-301, 1995.
4. Abraham E: Neutrophils and acute lung injury. Crit Care Med 31(4 suppl):S195-S199, 2003.
5. Fan J, Ye RD, Malik AB: Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 281:L1037-L1050, 2001.
6. Guo RF, Ward PA: Role of C5a in inflammatory responses. Annu Rev Immunol 23:821-852, 2005.
7. Lentsch AB, Ward PA: Regulation of experimental lung inflammation. Respir Physiol 128:17-22, 2001.
8. Lo SK, Everitt J, Gu J, Malik AB: Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest 89:981-988, 1992.
9. Shanley TP, Warner RL, Ward PA: The role of cytokines and adhesion molecules in the development of inflammatory injury. Mol Med Today 1:40-45, 1995.
10. Strieter RM, Kunkel SL, Keane MP, Standiford TJ: Chemokines in lung injury: Thomas A. Neff lecture. Chest 116(1 suppl):103S-110S, 1999.
11. -. Responses by rat alveolar macrophages. Am J Pathol 130:489-495, 1988.
12. Petty TL: Protease mechanisms in the pathogenesis of acute lung injury. Ann N Y Acad Sci 624:267-277, 1991.
13. Schraufstatter IU, Revak SD, Cochrane CG: Proteases and oxidants in experimental pulmonary inflammatory injury. J Clin Invest 73:1175-1184, 1984.
14. Gaudino G, Follenzi A, Naldini L, Collesi C, Santoro M, Gallo KA, Godowski PJ, Comoglio PM: Ron is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J 13:3524-3532, 1994.
15. Iwama A, Okano K, Sudo T, Matsuda Y, Suda T: Molecular cloning of a novel receptor tyrosine kinase gene, STK, derived from enriched hematopoietic stem cells. Blood 83:3160-3169, 1994.
16. Iwama A, Wang MH, Yamaguchi N, Ohno N, Okano K, Sudo T, Takeya M, Gervais F, Morissette C, Leonard EJ, et al.: Terminal differentiation of murine resident peritoneal macrophages is characterized by expression of the STK protein tyrosine kinase, a receptor for macrophage-stimulating protein. Blood 86:3394-3403, 1995.
17. Quantin B, Schuhbaur B, Gesnel MC, Doll'e P, Breathnach R: Restricted expression of the ron gene encoding the macrophage stimulating protein receptor during mouse development. Dev Dyn 204:383-390, 1995.
18. Leonard EJ: Biological aspects of macrophage-stimulating protein (MSP) and its receptor. Ciba Found Symp 212:183-191, 1997. [discussion 192Y197].
19. Waltz SE, McDowell SA, Muraoka RS, Air EL, Flick LM, Chen YQ, Wang MH, Degen SJ: Functional characterization of domains contained in hepatocyte growth factor-like protein. J Biol Chem 272(48):30526-30537, 1997.
20. Correll PH, Iwama A, Tondat S, Mayrhofer G, Suda T, Bernstein A: Deregulated inflammatory response in mice lacking the STK/Ron receptor tyrosine kinase. Genes Funct 1:69-83, 1997.
21. Leonis MA, Toney-Earley K, Degen SJ, Waltz SE: Deletion of the Ron receptor tyrosine kinase domain in mice provides protection from endotoxin-induced acute liver failure. Hepatology 36(5):1053-1060, 2002.
22. Mallakin A, Kutcher LW, McDowell SA, Kong S, Schuster R, Lentsch AB, Aronow BJ, Leikauf GD, Waltz SE: Gene expression profiles of Mst1r-deficient mice during nickel-induced acute lung injury. Am J Respir Cell Mol Biol 34:15-27, 2006.
23. McDowell SA, Mallakin A, Bachurski CJ, Toney-Earley K, Prows DR, Bruno T, Kaestner KH, Witte DP, Melin-Aldana H, Degen SJ, et al.: The role of the receptor tyrosine kinase Ron in nickel-induced acute lung injury. Am J Respir Cell Mol Biol 26:99-104, 2002.
24. Waltz SE, Eaton L, Toney-Earley K, Hess KA, Peace BE, Ihlendorf JR, Wang MH, Kaestner KH, Degen SJ: Ron-mediated cytoplasmic signaling is dispensable for viability but is required to limit inflammatory responses. J Clin Invest 108:567-576, 2001.
25. Chen YQ, Fisher JH, Wang MH: Activation of the Ron receptor tyrosine kinase inhibits inducible nitric oxide synthase (iNOS) expression by murine peritoneal exudate macrophages: phosphatidylinositol-3 kinase is required for Ron-mediated inhibition of iNOS expression. J Immunol 161:4950-4959, 1998.
26. Liu QP, Fruit K, Ward J, Correll PH: Negative regulation of macrophage activation in response to IFN-gamma and lipopolysaccharide by the STK/Ron receptor tyrosine kinase. J Immunol 163:6606-6613, 1999.
27. Morrison AC, Wilson CB, Ray M, Correll PH: Macrophage-stimulating protein, the ligand for the stem cellYderived tyrosine kinase/Ron receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol 172:1825-1832, 2004.
28. Zhou YQ, Chen YQ, Fisher JH, Wang MH: Activation of the Ron receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages. J Biol Chem 277:38104-38110, 2002.
29. Deryckere F, Gannon F: A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16:405, 1994.
30. Schierwagen C, Bylund-Fellenius AC, Lundberg C: Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 23:179-186, 1990.
31. Lentsch AB, Czermak BJ, Bless NM, Ward PA: NF-kappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement. Am J Pathol 152:1327-1336, 1998.
32. Nathens AB, Bitar R, Davreux C, Bujard M, Marshall JC, Dackiw AP, Watson RW, Rotstein OD: Pyrrolidine dithiocarbamate attenuates endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol 17:608-616, 1997.
33. Kristof AS, Goldberg P, Laubach V, Hussain SN: Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am J Respir Crit Care Med 158:1883-1889, 1998.
34. Numata M, Suzuki S, Miyazawa N, Miyashita A, Nagashima Y, Inoue S, Kaneko T, Okubo T: Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol 160:3031-3037, 1998.
35. Shanley TP, Zhao B, Macariola DR, Denenberg A, Salzman AL, Ward PA: Role of nitric oxide in acute lung inflammation: lessons learned from the inducible nitric oxide synthase knockout mouse. Crit Care Med 30:1960-1968, 2002.
36. Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM, Ignarro LJ: Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochem Biophys Res Commun 191:1301-1308, 1993.
37. Ulich TR, Watson LR, Yin SM, Guo KZ, Wang P, Thang H, del Castillo J: The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1Y, and TNF-induced inflammatory infiltrate. Am J Pathol 138:1485-1496, 1991.
38. Follenzi A, Bakovic S, Gual P, Stella MC, Longati P, Comoglio PM: Cross-talk between the proto-oncogenes Met and Ron. Oncogene 19:3041-3049, 2000.
39. Mera A, Suga M, Ando M, Suda T, Yamaguchi N: Induction of cell shape changes through activation of the interleukin-3 common beta chain receptor by the Ron receptor-type tyrosine kinase. J Biol Chem 274:15766-15774, 1999.
40. Peace BE, Hill KJ, Degen SJ, Waltz SE: Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor. Exp Cell Res 289:317-325, 2003.
41. Warner RL, Paine R 3rd, Christensen PJ, Marletta MA, Richards MK, Wilcoxen SE, Ward PA: Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am J Respir Cell Mol Biol 12:649-661, 1995.
42. Bless NM, Huber-Lang M, Guo RF, Warner RL, Schmal H, Czermak BJ, Shanley TP, Crouch LD, Lentsch AB, Sarma V, et al.: Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats. J Immunol 164:2650-2659, 2000.
43. Shanley TP, Foreback JL, Remick DG, Ulich TR, Kunkel SL, Ward PA: Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury. Am J Pathol 151:193-203, 1997.
44. Shanley TP, Schmal H, Warner RL, Schmid E, Friedl HP, Ward PA: Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J Immunol 158:3439-3448, 1997.